TET2 and acute lymphoblastic leukemia: Meta-analysis of targeted exome sequencing, whole exome sequencing, and whole genome sequencing of leukemic blasts from 854 T-ALL patients (Dataset S1) confirmed that TET2 mutations were infrequent in T-ALL (0.7%) (Fig. 1A and SI Appendix, Fig. S1A).